SCHEMBL7053932

SCHEMBL7053932

CCOC(=O)CCCCCCCC=CCCCCCCO

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ ALOX15 P16050 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ HSD17B10 Q99714 1/20 0.71
▸ TDP1 Q9NUW8 1/20 0.71
▸ NR1I2 O75469 1/20 0.60
▸ PGR P06401 1/20 0.60
▸ ADORA3 P0DMS8 1/20 0.60
▸ PTGS2 P35354 1/20 0.60
▸ PDE4D Q08499 1/20 0.60
▸ DGKA P23743 1/20 0.55
▸ FAAH O00519 2/20 0.54
▸ MGLL Q99685 1/20 0.54
▸ CNR2 P34972 1/20 0.53
▸ PRKCA P17252 2/20 0.52
▸ PRKCE Q02156 1/20 0.52
▸ PRKCQ Q04759 1/20 0.52
▸ PRKCD Q05655 1/20 0.52
▸ EPHX2 P34913 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18960607 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL18960823 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL28537632 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL18960608 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL18960824 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL28528192 1.00 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL7587955 0.96 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
Ethyl Oleate SCHEMBL17443164 0.95 ALOX15 (0.65) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL11302612 0.93 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10
SCHEMBL11302609 0.93 ALDH1A1 (0.71) ALDH1A1CYP3A4ALOX15TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6639089-B2 Therapy, side effect reduction SODA AROMATIC CO., LTD. 2003-10-28 — — US disclosed
US-20030055105-A1 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) 2003-03-20 — — US disclosed
EP-1249236-A1 ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS SODA AROMATIC COMPANY, LIMITED (JP) 2002-10-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055105-A1 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids ALOX5, ELOVL5, ELOVL3 ALDH1A1 397/4885CYP3A4 475/4885ALOX15 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback